Last mentioned: 14h ago
Official Reporting
MHRA and GOV.UK release data confirming the surge in neurotech and AI testing activity.
Record Achievement
Total CINs for the year reach 137, a new historical high for the agency.
IDAP Expansion
The MHRA expands the Innovative Devices Access Pathway to include more AI-driven startups.
Baseline Growth
UK concludes 2024 with 104 clinical investigation notifications.
Singapore’s National University Health System (NUHS) is transitioning from pilot AI projects to a full-scale enterprise deployment of predictive analytics. This strategic shift aims to integrate real-time data into clinical decision-making and operational workflows to support value-based care and future reimbursement models.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) reported a record 137 clinical investigation notifications in 2025, a 32% increase over the previous year. This surge is driven by a strategic regulatory pivot toward AI-driven diagnostics and brain-computer interfaces, signaling the UK's intent to lead in high-risk medical innovation.